Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The challenge of assuring continued post-trial access to beneficial treatment.

× No keyword cloud information.

12 in total

1. Ethical issues in HIV prevention research with people who inject drugs.

Authors: Jeremy Sugarman; Scott M Rose; David Metzger
Journal: Clin Trials Date: 2013-10-14 Impact factor: 2.486

2. Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma.

Authors: Yoram Unguru; Steven Joffe; Conrad V Fernandez; Alice L Yu
Journal: J Clin Oncol Date: 2013-01-07 Impact factor: 44.544

Review 3. Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.

Authors: Pamela Andanda; Jane Wathuta
Journal: Med Health Care Philos Date: 2018-03

4. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.

Authors: Andrea L Ciaranello; Rochelle P Walensky; Paul E Sax; Yuchiao Chang; Kenneth A Freedberg; Joel S Weissman
Journal: HIV Clin Trials Date: 2009 Jan-Feb

5. Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study.

Authors: N Sofaer; C Thiessen; S D Goold; J Ballou; K A Getz; G Koski; R A Krueger; J S Weissman
Journal: J Med Ethics Date: 2009-03 Impact factor: 2.903

6. Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders' views in Kenya.

Authors: Geoffrey M Lairumbi; Michael Parker; Raymond Fitzpatrick; Michael C English
Journal: Philos Ethics Humanit Med Date: 2012-01-17 Impact factor: 2.464

7. Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.

Authors: Neema Sofaer; Daniel Strech
Journal: Public Health Ethics Date: 2011-07-11 Impact factor: 1.940

8. Reciprocity-based reasons for benefiting research participants: most fail, the most plausible is problematic.

Authors: Neema Sofaer
Journal: Bioethics Date: 2013-12-06 Impact factor: 1.898

9. Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees.

Authors: Rebecca H Li; Mary C Wacholtz; Mark Barnes; Liam Boggs; Susan Callery-D'Amico; Amy Davis; Alla Digilova; David Forster; Kate Heffernan; Maeve Luthin; Holly Fernandez Lynch; Lindsay McNair; Jennifer E Miller; Jacquelyn Murphy; Luann Van Campen; Mark Wilenzick; Delia Wolf; Cris Woolston; Carmen Aldinger; Barbara E Bierer
Journal: J Med Ethics Date: 2016-01-25 Impact factor: 2.903

10. The 'experimental public' in longitudinal health research: views of local leaders and service providers in rural South Africa.

Authors: Rhian Twine; Gillian Lewando Hundt; Kathleen Kahn
Journal: Glob Health Res Policy Date: 2017-09-06